Radionuclide imaging helps predict cardiac events in heart patients

03/2/2010 | Modern Medicine

Radionuclide imaging using myocardial iodine-123 meta-iodobenzylguanidine scintigraphy to evaluate how the myocardium is stimulated helps predict cardiac events in patients with heart failure and reduced left ventricular ejection fraction, a study said. The study involved 961 patients with heart failure and 35% or less LVEF.

View Full Article in:

Modern Medicine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY